Maiden US Laboratory FoodPrint® installation,
hVIVO PLC (AIM:HVO) £5.2m RSV contract and Notice of Trading update
£5.2m RSV human challenge study contract with global biotechnology company in Asia Pacific and Notice of Trading Update
Many Chinese return to normal activity after COVID infection
People in China’s major cities of Beijing, Shanghai, and Wuhan braved the cold to resume regular activity Monday. They were optimistic about the economic recovery of more people who have
Polarean Imaging PLC (AIM:POLX) FDA Approves XENOVIEWT (Xe 129 hyperpolarized)
FDA Approves Polarean’s XENOVIEW™ (xenon Xe 129 hyperpolarized) for use with MRI for the evaluation of lung ventilation
SkinBioTherapeutics (AIM:SBTX) Report and Accounts, and Provision Update
Annual Report and Accounts
Poolbeg Pharma PLC (AIM:POLB) identifies novel RSV drug candidates
Poolbeg identifies new potential drug candidates for Respiratory Syncytial Virus infections as part of Artificial Intelligence Programme
hVIVO PLC (AIM:HVO) Imutex Phase I data published
Phase I results for Imutex’s mosquito vaccine candidate published in leading peer-reviewed journal
Poolbeg Pharma PLC (AIM:POLB) POLB 001 LPS human challenge trial completed
POLB 001 LPS human challenge clinical trial successfully completed
Ex-boyfriend of Elizabeth Holmes sentenced to almost 13 years imprisonment for Theranos fraud
Judge sentences Elizabeth Holmes, a former aide to the founder of Theranos, to 15 years in prison for convincing people to trust her failed blood-testing startup.
ValiRx PLC (AIM:VAL) Quarterly Operational and Strategy Update
London, UK – ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women’s health, today provides an update on operational activities and strategy.
Novacyt S.A. (AIM:NCYT) Approval of genesig COVID-19 3G PCR test in UK
Approval of genesig® COVID-19 3G PCR test in the UK under CTDA legislation